期刊
ACS CHEMICAL NEUROSCIENCE
卷 1, 期 8, 页码 533-534出版社
AMER CHEMICAL SOC
DOI: 10.1021/cn1000606
关键词
Gamma-secretase; Alzheimer's disease; AD; neurodegeneration; LY450139; semagacestat
Semagacestat (LY450139) is a novel gamma-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD). Semagacestat is currently being studied in two phase III clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
